News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.

Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.

In early 2027, RECOVER will launch the next phase of its pediatric study, following more than 4,300 children, teens, and young adults over 2 years to learn how Long COVID changes as they grow up.
NIH invites investigators to apply for a new research opportunity, which funds pathobiology studies. Applicants can request use of data and biosamples from RECOVER observational studies and, for the first time, RECOVER clinical trials.
In 2026 so far, RECOVER has published new research findings across nearly all its different studies and will soon be enrolling participants for the next phases of the adult observational study and clinical trials.
Throughout this phase, RECOVER will continue to collect information from about 5,000 people for 2 years to build a deeper understanding of how Long COVID affects people over time.
ISCORE, a RECOVER hub spanning 10 states and Puerto Rico, is bringing Long COVID studies to communities often underfunded in research, drawing on decades of HIV experience to tackle another new infectious disease.
RECOVER scientists, study participants, and Representatives are working together to make new discoveries about Long COVID and how to diagnose, prevent, and treat its symptoms.
As RECOVER’s adult observational study moves to the next phase, researchers continue to explore the various causes of common Long COVID symptoms, such as difficulty breathing.
At the RECOVER Research Review (R3) Seminar held on April 14, RECOVER researchers presented findings on how Long COVID affects the brain, including difficulties with thinking clearly, memory, and concentration. They also outlined future research opportunities to better understand neurocognitive symptoms and how other body systems impact brain health.